Results 101 to 110 of about 17,995 (248)

Manifestation of morphea in a patient with myasthenia gravis under therapy with zilucoplan

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Phoebe Wellmann, Jana Zschüntzsch, Michael P. Schön, Rotraut Mössner   +3 more
wiley   +1 more source

Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment [PDF]

, 2017
Marina Senek, Sten‐Magnus Aquilonius, Håkan Askmark, Filip Bergquist, Radu Constantinescu, Anders Ericsson, Sara Lycke, Alexander Medvedev, Mevludin Memedi, Fredrik Ohlsson, Jack Spira, Jerker Westin, Dag Nyholm   +12 more
openalex   +1 more source

Constructing a Personalized Treatment Rule for Initial Therapy in Early Parkinson's Disease

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 46, Issue 1, January 2026.
ABSTRACT Background Dopaminergic therapies such as levodopa and dopamine receptor agonists (DRA) improve motor function in people with Parkinson's disease. These therapies are also linked to the advent of motor complications such as dyskinesias and wearing‐off episodes.
Zachary P. Brehm, Ruth B. Schneider, Charles S. Venuto, Greta Smith, Cuong Tuan Pham, Michael P. McDermott, Ashkan Ertefaie   +6 more
wiley   +1 more source

Carbidopa/levodopa dose elevation and safety concerns in Parkinson's patients: a cross-sectional and cohort design

BMJ Open, 2012
Objective Sinemet, a combination drug containing carbidopa and levodopa is considered the gold standard therapy for the treatment of Parkinson's disease (PD).
Michael S Okun, Peter Schmidt, David W Brodell, Nicole T Stanford, Charles E Jacobson   +4 more
doaj   +1 more source

Amblyopia [PDF]

, 2016
Amblyopia is, aside from refractive error, the most common cause of visual loss in children. Thus amblyopia is a serious public health issue. When diagnosed and treated early, the visual losses may be easily reversed.
Levi, DM
core  

Problems related to levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease [PDF]

, 2017
Background: Continuous levodopa-carbidopa intestinal gel (LCIG) diminishes daily off time and dyskinesia in patients with advanced Parkinsons disease (PD).
Ahlskog, Antonini, Deep-Brain Stimulation for Parkinson's Disease Study, Group, del-Hoyo-Francisco, Devos, Epstein, Fernandez, Fernandez, Gauderer, Horstink, Klostermann, Krones, Laar, Lang, Lopiano, Martino, Merola, Nilsson, Nyholm, Olanow, Palhagen, Pickut, Schapiro, Trenkwalder, Udd, Wirdefeldt   +25 more
core   +1 more source

Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale

Geriatrics &Gerontology International, Volume 26, Issue 1, January 2026.
ABSTRACT The increased anticholinergic burden caused by medications in older adults is one of the adverse drug reactions of particular concern, as it can exacerbate the onset of geriatric syndromes or induce cognitive dysfunction, and is also related to the issue of polypharmacy.
Masaki Mogi, Shuang Liu, Yasuyuki Suzuki, Yuuka Shibata, Shizuo Yamada   +4 more
wiley   +1 more source

Az amin oxidázok és a NADPH-oxidáz szerepe az ér- és neuronkárosodások kialakulásában (patomechanizmus és gyógyszeres befolyásolás) = Amine-oxidases and NADPH-oxidase-studies on their contribution to vascular and neuronal damages (pathomechanism and drug targets) [PDF]

, 2011
A selegilinnek és N-proragyl származékainak (dezmetil-deprenyl, deprenyl-N-oxid) neuroprotektív hatását tanulmányoztuk A-2058 melanóma sejtkultúrán. A sejtkárosodást BSO toxinnal váltottuk ki, mely gátolja a glutation szintézisét, valamint csökkenti az ...
Békési, Gábor, Egresits, József János, Halász, Attila Sándor, Kiss, István, Magyar, Kálmán, Nemcsik, János, Pálfi, Melinda, Szökő, Éva, Tábi, Tamás, Török, Tamás   +9 more
core  

Is Parkinson's disease a vesicular dopamine storage disorder?: Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum [PDF]

, 2014
The cause of degeneration of nigrostriatal dopamine (DA) neurons in idiopathic Parkinson’s disease (PD) is still unknown. Intraneuronally, DA is largely confined to synaptic vesicles where it is protected from metabolic breakdown.
Blesa, Javier, Cavada, Carmen, Hornykiewicz, Oleh, Obeso, José A., Pifl, Christian, Rajput, Alex, Rajput, Ali H., Reither, Harald   +7 more
core   +3 more sources

A cost-effectiveness analysis of levodopa/carbidopa intestinal gel compared to standard care in late stage Parkinson’s disease in the UK [PDF]

, 2011
Julia Lowin, Annika Bergman, К. Ray Chaudhuri, Leslie J. Findley, Claudia Roeder, Mathias Schifflers, Eifiona Wood, Stephen Morris   +7 more
openalex   +1 more source